The GLP-1 news channel walks through three recent filings tied to retatrutide, Eli Lilly's experimental weight loss drug, and what they could change for patients.
Recap by typeshit. Full story at On The Pen™ GLP-1 News.
A short social clip runs through the daily checklist of a GLP-1 routine: injections, water, protein and keeping tabs on progress.
12:50
Alex Wallace, who bills himself as a peptide expert, gives his response to what Dr. Mike has said about peptides. Details beyond the title are thin.
A search result from Polskie Radio on the approval status of tirzepatide for weight loss, with no further detail provided beyond the question itself.
A Facebook post credits Novo Nordisk's GLP-1 drugs with strong results in obesity and type 2 diabetes, plus lower risk of other conditions.
Medscape reports that people with hidradenitis suppurativa begin GLP-1 drugs sooner in their disease course than people with psoriasis do.
The October Pharmacy Times Community issue covers clinical topics for pharmacists, from GLP-1 safety questions to everyday medication management.
Loading…